December 08, 2023
It is with deep sorrow that we announce the news of the passing of internationally renowned psychiatrist John A. Talbott, MD, former Chair of Psychiatry and Professor Emeritus at the University of Maryland School of Medicine (UMSOM).
Obituary in The New York Times
Dr. Talbott was memorialized in The New York Times as a "champion of care for the mentally ill." He raised awareness of the dire condition of those with mental illness who were left homeless after mass closures of state mental hospitals during the 1970s. During his presidency of the American Psychiatric Association, the organization released its first major study in 1984 of those experiencing mental illness and homelessness. The report estimated that 50 percent of homeless people had chronic mental illness.
Hailed as a leader's leader, Dr. Talbott served as the beloved chairman of the UMSOM Department of Psychiatry for 15 years. His focus on chronic mental illness not only positioned the school as a leading institution in the specialty, but revolutionized healthcare for populations with the most persistent and severe mental illnesses.
Dr. Talbott joined UMSOM in 1985 after serving as an attending psychiatrist at New York Hospital and as President of the American Psychiatric Association. Prior to that, he served as a Captain of the U.S. Army Medical Corps, where he received a Bronze Star for his service in Vietnam. Through his military service, he became heavily involved in advancing veterans’ mental health and the treatment of post-traumatic stress symptoms.
He graduated with a BA degree from Harvard College (1957), an MD degree from Columbia College of Physicians and Surgeons (1961), and completed his residency training at Columbia Presbyterian Hospital/New York State Psychiatric Institute (1965) and the Columbia University Psychoanalytic Center (1971).
Throughout Dr. Talbott’s tenure, he was highly regarded for his thought leadership authoring 20 books and 200 publications while also leading national psychiatry organizations. His prestigious appointments include Editor-Emeritus of Psychiatric Services, former President of the American Association of Chairmen of Departments of Psychiatry, American Psychiatric Association and former Vice President of the American Board of Psychiatry and Neurology.
He is remembered as an tireless advocate for change in mental health services, public policy and often regarded as early champion, decades ago, for the deinstitutionalization of “asylums”.
Dr. Talbott continues to have a permanent foundational impact on medical education at UMSOM through the HELPERS-Pro Professionalism Project. As a founding director of the program, he was committed to promoting ideals of professionalism and compassion in faculty and house staff throughout the medical school experience.
Outside of his career in medicine, he enjoyed French cuisine and became a published food critic. His reviews were featured in Chowhound, eGullet and his own blog “John Talbott’s Paris”, which showcased lunchtime meals and young chefs on the rise. Dr. Talbott is survived by his wife Susan Talbott, a psychiatric and public health nurse, two daughters, sister and six grandchildren.
Both the Capital Gazette and the Baltimore Sun featured obituaries honoring his legacy.
Contact
Office of Public Affairs
655 West Baltimore Street
Bressler Research Building 14-002
Baltimore, Maryland 21201-1559
Contact Media Relations
(410) 706-5260
Related stories
Monday, June 10, 2024
Tribute to John A. Talbott, MD
Psychiatry suffered a major loss on November 29, 2023, when John A. Talbott, MD passed away at the age of 88. A pioneer in the field of Community Psychiatry, he relentlessly advocated for some of the most disadvantaged people in our collective communities– individuals with severe and persistent mental illness–a population that remains stigmatized and forgotten. His career was both defined and fueled by his rage against the neglect and indifference to these sickest members of our society. His advocacy included obtaining the necessary resources and access to care, as well as the need for empathy and understanding for the "person" trapped in the throes of severe mental illness.
Tuesday, December 19, 2023
UM School of Medicine Review Highlights Rise in Psychiatric Disorders Linked to Increased Cannabis Use
The widespread use of cannabis (marijuana) and its increased potency are associated with a rise in cannabis-related psychiatric conditions, according to a new University of Maryland School of Medicine (UMSOM) review article that was recently published in the New England Journal of Medicine. It highlights the urgent need for doctors to screen for and treat patients who are experiencing symptoms of cannabis use disorder, which means they are experiencing significant problems from their use of the drug.
Friday, December 08, 2023
UM School of Medicine Mourns the Loss of Dynamic Researcher, Chair, World Traveler, Giuseppe Inesi, MD
The University of Maryland School of Medicine mourns the loss of a dynamic researcher and teacher, Giuseppe Inesi, MD. He passed away on November 12 in Tiburon, California of Alzheimer’s disease.
Friday, December 08, 2023
In Memoriam: UM School of Medicine Honors the Life of Outstanding Educator and Former Radiology Vice Chair, Robert D. Pugatch, MD
The University of Maryland School of Medicine (UMSOM) community is deeply saddened to share the passing of Robert D. Pugatch, MD, a beloved educator and former Vice Chair of the Department of Diagnostic Radiology and Nuclear Medicine. An expert in thoracic imaging, he was passionately known as one of the best in medical education, dedicated to mentoring and training generations of radiologists and physicians.
Friday, January 06, 2023
UM School of Medicine Scientists Create First Extensive Brain Cell Data Repository
Neuroscience researchers now have access to 50 million brain cells to better understand how the brain develops and functions or changes with disease or trauma. Last month, scientists at the University of Maryland School of Medicine’s (UMSOM) Institute for Genome Sciences (IGS) unveiled a “one-stop shop” for brain cell data called the Neuroscience Multi-Omic Archive (NeMO Archive). This archive is now available to neuroscience researchers to transform their understanding of the complex workings of the brain.
Tuesday, August 30, 2022
Effects of Drugs in Mice can Depend on the Sex of the Human Experimenter
University of Maryland School of Medicine researchers demonstrated that a stress response in the brain is essential for ketamine’s antidepressant response in mice suggesting new ways to improve antidepressant therapy for patients who do not respond to the treatment.
Thursday, September 23, 2021
Dr. Deanna Kelly Appointed New Chair of Institutional Review Board for the Maryland Department of Health
Deanna Kelly, PharmD, Professor of Psychiatry at the University of Maryland School of Medicine (UMSOM), has been appointed to lead the prestigious committee of experts who review and approve all proposed research projects involving human participants for the Maryland Department of Health (MDH). She will chair the MDH Institutional Review Board (IRB) for the next four years, a position she started in July.
Wednesday, June 07, 2017
Dr. Jill RachBeisel Named Vice Chair for Clinical Affairs in UM School of Medicine’s Department of Psychiatry
Bankole A. Johnson, DSc, MD, MBChB, The Dr. Irving J. Taylor Professor and Chair for the Department of Psychiatry, Professor of Pharmacology, Anatomy and Neurobiology, along with UM SOM Dean E. Albert Reece, MD, PhD, MBA, announced today that Jill RachBeisel, MD, Associate Professor of Psychiatry, has been named Vice Chair for Clinical Affairs for the UM SOM Department of Psychiatry, commencing at the start of the next academic year.
Friday, April 28, 2017
School of Medicine Community Mourns Passing of Richard Horenstein, MD, JD
Richard B. Horenstein, MD, JD, Associate Professor of Medicine at UM SOM, passed away on March 23, 2017. A graduate of Yale Law School and Jefferson Medical College, and a Fellow in Endocrinology at the UM Medical Center. He had extensive experience in clinical research and had implemented several large translational gene x environment and pharmacogenetics studies at the UM SOM.